The synergistic action of TLR7 and imiquimod (IMQ, a TLR7 ligand) induces both the cytokines required to activate the Th17 pathway and the proinflammatory factor expression for psoriasis pathogenesis, and promotes IL-1, IL-2, and TNF-α production by DCs [11]. This evidence concerns the gene TNF and psoriasis.